US Stock MarketDetailed Quotes
FOLD Amicus Therapeutics
- 9.660
- +0.160+1.68%
Close Nov 22 16:00 ET
- 9.880
- +0.220+2.28%
Post 18:53 ET
2.89BMarket Cap-28411P/E (TTM)
9.780High9.460Low1.93MVolume9.510Open9.500Pre Close18.57MTurnover0.79%Turnover RatioLossP/E (Static)298.81MShares14.57052wk High16.15P/B2.37BFloat Cap9.02052wk Low--Dividend TTM245.30MShs Float25.390Historical High--Div YieldTTM3.37%Amplitude1.765Historical Low9.646Avg Price1Lot Size
Amicus Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 36.73%141.52M | 34.04%126.67M | 27.97%110.4M | 21.30%399.36M | 30.63%115.08M | 26.70%103.5M | 17.06%94.5M | 9.60%86.27M | 7.76%329.23M | 7.23%88.1M |
| Operating revenue | 36.73%141.52M | 34.04%126.67M | 27.97%110.4M | 21.30%399.36M | 30.63%115.08M | 26.70%103.5M | 17.06%94.5M | 9.60%86.27M | 7.76%329.23M | 7.23%88.1M |
| Cost of revenue | 33.51%13.28M | 23.56%11.26M | 95.43%13.57M | -3.30%37.33M | 20.67%11.32M | -25.97%9.95M | 11.19%9.11M | -8.44%6.94M | 11.99%38.6M | 19.53%9.38M |
| Gross profit | 37.07%128.24M | 35.16%115.41M | 22.07%96.84M | 24.57%362.03M | 31.82%103.76M | 37.07%93.56M | 17.72%85.39M | 11.52%79.33M | 7.23%290.63M | 5.93%78.71M |
| Operating expense | -4.74%103.44M | -2.27%100.44M | 1.54%118.51M | -12.03%435.52M | -10.05%107.45M | 6.95%108.58M | -22.74%102.78M | -17.25%116.71M | 5.12%495.06M | -17.45%119.46M |
| Selling and administrative expenses | 14.40%75.11M | 12.46%73.58M | 19.03%88.03M | 29.21%275.27M | 29.42%70.24M | 38.88%65.65M | 22.56%65.42M | 27.26%73.96M | 10.55%213.04M | -5.78%54.27M |
| Research and development costs | -35.73%26.16M | -29.78%24.68M | -31.74%28.33M | -44.92%152.38M | -45.16%35.03M | -23.16%40.7M | -55.12%35.15M | -49.09%41.5M | 1.70%276.68M | -25.38%63.87M |
| Depreciation amortization depletion | -2.60%2.17M | -1.09%2.18M | 71.36%2.15M | 47.38%7.87M | 66.44%2.18M | 73.25%2.23M | 65.37%2.21M | -10.91%1.26M | -13.96%5.34M | -13.64%1.31M |
| -Depreciation and amortization | -2.60%2.17M | -1.09%2.18M | 71.36%2.15M | 47.38%7.87M | 66.44%2.18M | 73.25%2.23M | 65.37%2.21M | -10.91%1.26M | -13.96%5.34M | -13.64%1.31M |
| Operating profit | 265.04%24.8M | 186.07%14.97M | 42.02%-21.68M | 64.05%-73.49M | 90.94%-3.69M | 54.83%-15.03M | 71.26%-17.39M | 46.52%-37.39M | -2.25%-204.43M | 42.13%-40.74M |
| Net non-operating interest income expense | -0.83%-11.61M | -3.60%-11.14M | -12.97%-10.9M | -26.33%-43.07M | -22.28%-11.16M | -27.14%-11.52M | -36.12%-10.76M | -20.35%-9.65M | -6.67%-34.1M | -14.35%-9.12M |
| Non-operating interest income | -26.51%1.08M | -21.13%1.37M | -29.97%1.54M | 134.06%7.08M | -15.26%1.67M | 161.28%1.47M | 387.92%1.74M | 1,553.38%2.2M | 494.11%3.02M | 960.22%1.97M |
| Non-operating interest expense | -2.26%12.69M | 0.16%12.51M | 5.00%12.44M | 35.10%50.15M | 15.61%12.83M | 34.99%12.99M | 51.29%12.49M | 45.38%11.84M | 14.31%37.12M | 35.90%11.1M |
| Other net income (expense) | -448.53%-6.41M | 69.96%-3.72M | -77.91%-11.01M | -853.27%-33.54M | 16.82%-16.81M | -85.93%1.84M | -272.98%-12.37M | -75.52%-6.19M | 63.63%-3.52M | -960.44%-20.21M |
| Special income (charges) | -57.54%-3.14M | --0 | -2,308.37%-6.05M | -129.40%-17.65M | -779.61%-13.93M | -251.85%-2M | -1,179.13%-1.47M | 95.38%-251K | -13.63%-7.69M | 8.65%-1.58M |
| -Less：Restructuring and merger&acquisition | 57.54%3.14M | --0 | 2,308.37%6.05M | 139.61%2.58M | --0 | 251.85%2M | 193.04%337K | 121.13%251K | -83.45%1.08M | -8.65%1.58M |
| -Less:Other special charges | ---- | ---- | ---- | --13.93M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Write off | --0 | --0 | ---- | -82.86%1.13M | --0 | --0 | --1.13M | ---- | --6.62M | --0 |
| Other non- operating income (expenses) | -185.13%-3.26M | 65.91%-3.72M | 16.37%-4.97M | -480.41%-15.89M | 84.54%-2.88M | -71.89%3.83M | -250.00%-10.9M | -412.20%-5.94M | 243.95%4.18M | -10,730.23%-18.63M |
| Income before tax | 127.46%6.79M | 100.27%108K | 18.11%-43.58M | 37.98%-150.1M | 54.82%-31.66M | 15.58%-24.71M | 33.85%-40.52M | 34.66%-53.22M | -0.20%-242.04M | 12.72%-70.08M |
| Income tax | 532.03%13.51M | 482.14%15.81M | 1,785.02%4.84M | 127.11%1.48M | 115.36%2.18M | -177.75%-3.13M | 198.02%2.72M | -107.53%-287K | -161.43%-5.47M | -576.82%-14.21M |
| Net income | 68.81%-6.73M | 63.69%-15.7M | 8.53%-48.42M | 35.92%-151.58M | 39.42%-33.84M | 35.18%-21.58M | 30.45%-43.23M | 37.92%-52.93M | 5.55%-236.57M | 32.92%-55.87M |
| Net income continuous Operations | 68.81%-6.73M | 63.69%-15.7M | 8.53%-48.42M | 35.92%-151.58M | 39.42%-33.84M | 35.18%-21.58M | 30.45%-43.23M | 37.92%-52.93M | 5.55%-236.57M | 32.92%-55.87M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 68.81%-6.73M | 63.69%-15.7M | 8.53%-48.42M | 35.92%-151.58M | 39.42%-33.84M | 35.18%-21.58M | 30.45%-43.23M | 37.92%-52.93M | 5.55%-236.57M | 32.92%-55.87M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 68.81%-6.73M | 63.69%-15.7M | 8.53%-48.42M | 35.92%-151.58M | 39.42%-33.84M | 35.18%-21.58M | 30.45%-43.23M | 37.92%-52.93M | 5.55%-236.57M | 32.92%-55.87M |
| Basic earnings per share | 71.43%-0.02 | 66.67%-0.05 | 11.11%-0.16 | 37.80%-0.51 | 42.11%-0.11 | 41.67%-0.07 | 28.57%-0.15 | 40.00%-0.18 | 10.87%-0.82 | 34.48%-0.19 |
| Diluted earnings per share | 71.43%-0.02 | 66.67%-0.05 | 11.11%-0.16 | 37.80%-0.51 | 42.11%-0.11 | 41.67%-0.07 | 28.57%-0.15 | 40.00%-0.18 | 10.87%-0.82 | 34.48%-0.19 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data